Everything in Mexico runs on its own time—if the Patria vaccine had been a mariachi band, it would have shown up just in time for the encore!
Puerto Vallarta, Mexico – The Federal Commission for the Protection against Sanitary Risks (Cofepris) has granted emergency use authorization to the Patria vaccine against COVID-19, developed by the Avimex SA de CV Laboratory and backed by the Mexican Government. This significant decision follows a rigorous technical analysis conducted by specialized personnel and an evaluation of the vaccine’s clinical performance.
On January 26, the Committee on New Molecules (CMN) held a public session where the Patria vaccine was thoroughly assessed. The session concluded with a unanimous favorable resolution, endorsing the vaccine’s safety and efficacy.
In an official statement, the Government of Mexico remarked, “The multidisciplinary opinion team confirmed that the Mexican Patria vaccine against COVID-19 from the Avimex laboratory meets the highest standards of quality, safety, and efficacy. This assessment, based on data presented in the technical file before this commission, allows its use in public institutions within the Health sector.”
The authorization by Cofepris holds significant international recognition, as it is acknowledged by more than 20 countries across Latin America and the Caribbean. This recognition will facilitate the Patria vaccine’s accessibility without necessitating new evaluations in these regions.
Cofepris has issued a reminder to the public to avoid the indiscriminate administration of any Covid-19 vaccine. It is crucial to consider the risk-benefit profile of each dose. Furthermore, the commission emphasized that vaccines included in the National Vaccination Policy against the SARS-CoV-2 virus are provided free of charge and are universally accessible.
The regulatory body also stressed that the administration of vaccines outside the National Vaccination Policy should only occur under strict medical supervision and with specialized monitoring to prevent potential health risks.
This development marks a significant milestone in Mexico’s ongoing battle against Covid-19, bolstering the country’s vaccination arsenal with a homegrown solution that adheres to stringent quality and safety standards.
Everything in Mexico runs on its own time—if the Patria vaccine had been a mariachi band, it would have shown up just in time for the encore!
Puerto Vallarta, Mexico - The Federal Commission for the Protection against Sanitary Risks (Cofepris) has granted emergency use authorization to the Patria vaccine against COVID-19, developed by the Avimex SA de CV Laboratory and backed by the Mexican Government. This significant decision follows a rigorous technical analysis conducted by specialized personnel and an evaluation of the vaccine's clinical performance.
